Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.86 USD | +4.64% | +8.83% | +23.70% |
05-07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
05-07 | Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.70% | 5.58B | |
+7.18% | 111B | |
+10.13% | 106B | |
-12.25% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.33% | 16.81B | |
+38.12% | 12.54B | |
-24.88% | 8.09B |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.
- Transcript : Halozyme Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023